IE821705L - Tablet making machine - Google Patents
Tablet making machineInfo
- Publication number
- IE821705L IE821705L IE821705A IE170582A IE821705L IE 821705 L IE821705 L IE 821705L IE 821705 A IE821705 A IE 821705A IE 170582 A IE170582 A IE 170582A IE 821705 L IE821705 L IE 821705L
- Authority
- IE
- Ireland
- Prior art keywords
- capsular
- polyosides
- bacteriae
- give
- retained material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside. 1. Claims (for the Contracting State AT) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114842A FR2510606A1 (en) | 1981-07-30 | 1981-07-30 | PROCESS FOR OBTAINING CAPSULAR POLYOSIDES, CAPSULAR POLYOSIDES THUS OBTAINED AND THEIR APPLICATION TO THE PREPARATION OF VACCINES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE821705L true IE821705L (en) | 1983-01-30 |
| IE53582B1 IE53582B1 (en) | 1988-12-21 |
Family
ID=9261011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1705/82A IE53582B1 (en) | 1981-07-30 | 1982-07-15 | Process for the production of capsular polyosides,capsular polyosides obtained thereby,and their application to the preparation of vaccines |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0071515B1 (en) |
| AT (1) | ATE16244T1 (en) |
| CA (1) | CA1206905A (en) |
| DD (1) | DD202623A5 (en) |
| DE (1) | DE3267160D1 (en) |
| DK (1) | DK327182A (en) |
| ES (1) | ES8305827A1 (en) |
| FR (1) | FR2510606A1 (en) |
| IE (1) | IE53582B1 (en) |
| NO (1) | NO159394C (en) |
| PT (1) | PT75301B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3683844D1 (en) * | 1986-03-27 | 1992-03-19 | Schweiz Serum & Impfinst | VACCINE OF KLEBSIELLA CAPSULPOLYSACCHARID. |
| US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| EP1967591A3 (en) * | 2000-03-16 | 2008-12-03 | The Children's Hospital Of Philadelphia | Method of assessing the usefulness of a test compound for alleviating a pneumococcal infection in an animal |
| NZ511680A (en) | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
| GB0522303D0 (en) * | 2005-11-01 | 2005-12-07 | Chiron Srl | Culture method |
| WO2008129559A2 (en) | 2007-04-23 | 2008-10-30 | Serum Institute Of India Ltd | Antigenic polysaccharides and process for their preparation |
| WO2011148382A1 (en) | 2010-05-28 | 2011-12-01 | Biological E Limited | An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol. |
| WO2011151841A1 (en) * | 2010-05-31 | 2011-12-08 | Panacea Biotec Limited | Fermentation process for streptococcus pneumoniae |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| CA3048981A1 (en) | 2016-12-30 | 2018-07-05 | Sutrovax, Inc. | Polypeptide-antigen conjugates with non-natural amino acids |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| WO2024062494A1 (en) | 2022-09-19 | 2024-03-28 | Biological E Limited | Method for the purification of capsular polysaccharides |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
| US2528972A (en) * | 1947-05-15 | 1950-11-07 | Western Reserve University | Prophylactic toxoid compound and method of making same |
| FR2407262A1 (en) * | 1977-10-27 | 1979-05-25 | Cassenne Lab Sa | NEW POLYSACCHARIDES MICROBIAL BODY EXTRACTS OF HAEMOPHILUS INFLUENZAE, PROCESS FOR THE PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS OF THESE NEW PRODUCTS |
| CA1115210A (en) * | 1977-11-28 | 1981-12-29 | Dennis J. Carlo | Pneumococcal vaccine |
| US4264764A (en) * | 1979-01-12 | 1981-04-28 | Merck & Co., Inc. | Meningitis vaccine |
| US4221906A (en) * | 1979-03-19 | 1980-09-09 | American Cyanamid Company | Stabilization of pneumococcal polysaccharides |
| US4307080A (en) * | 1979-09-24 | 1981-12-22 | Merck & Co., Inc. | Meningitis vaccine |
| US4287173A (en) * | 1979-09-24 | 1981-09-01 | Merck & Co., Inc. | Vaccine for dental caries |
-
1981
- 1981-07-30 FR FR8114842A patent/FR2510606A1/en active Granted
-
1982
- 1982-07-15 IE IE1705/82A patent/IE53582B1/en unknown
- 1982-07-19 EP EP82401343A patent/EP0071515B1/en not_active Expired
- 1982-07-19 AT AT82401343T patent/ATE16244T1/en not_active IP Right Cessation
- 1982-07-19 DE DE8282401343T patent/DE3267160D1/en not_active Expired
- 1982-07-21 DK DK327182A patent/DK327182A/en not_active Application Discontinuation
- 1982-07-23 PT PT75301A patent/PT75301B/en not_active IP Right Cessation
- 1982-07-28 NO NO822592A patent/NO159394C/en unknown
- 1982-07-28 CA CA000408233A patent/CA1206905A/en not_active Expired
- 1982-07-29 ES ES514496A patent/ES8305827A1/en not_active Expired
- 1982-07-29 DD DD82242065A patent/DD202623A5/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2510606A1 (en) | 1983-02-04 |
| ATE16244T1 (en) | 1985-11-15 |
| CA1206905A (en) | 1986-07-02 |
| EP0071515A1 (en) | 1983-02-09 |
| DK327182A (en) | 1983-01-31 |
| FR2510606B1 (en) | 1984-10-26 |
| NO159394C (en) | 1988-12-21 |
| DD202623A5 (en) | 1983-09-28 |
| IE53582B1 (en) | 1988-12-21 |
| PT75301B (en) | 1984-07-31 |
| EP0071515B1 (en) | 1985-10-30 |
| PT75301A (en) | 1982-08-01 |
| ES514496A0 (en) | 1983-04-16 |
| DE3267160D1 (en) | 1985-12-05 |
| ES8305827A1 (en) | 1983-04-16 |
| NO159394B (en) | 1988-09-12 |
| NO822592L (en) | 1983-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE821705L (en) | Tablet making machine | |
| FR2373289A1 (en) | METHOD FOR THE PREPARATION OF A MASS OF CHARGED CELLS IN SUSPENSION IN A PHYSIOLOGICAL SOLUTION | |
| DE3270115D1 (en) | Method and apparatus for the cultivation of micro-organisms | |
| AT388174B (en) | METHOD FOR THE FERMENTATION OF CARBOHYDRATE-CONTAINING MEDIA USING BACTERIA | |
| ATE74381T1 (en) | HIGH MOLECULAR HOMOPOLYSACCHARIDES, PROCESSES FOR THEIR EXTRACELLULAR PRODUCTION AND APPLICATION, AS WELL AS THE CORRESPONDING MUSHROOM STRAIN. | |
| DE3369158D1 (en) | Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions | |
| FR2545099B1 (en) | NOVEL STRAIN OF TRICHODERMA HARZIANUM METHOD FOR ISOLATING THIS STRAIN, METHOD FOR CULTURING THIS STRAIN, NEW PEPTIDES PRODUCED BY THIS STRAIN, AND APPLICATION OF THIS STRAIN AND THESE NEW PEPTIDES OR THE PRODUCT OBTAINED BY THE CULTURE PROCESS AS A MEANS OF BIOLOGY IN THE FORM OF A PHYTOSANITARY PRODUCT | |
| ATE57457T1 (en) | POROUS PRODUCT FOR PLANT CULTURE AND PROCESS FOR PRODUCTION. | |
| AU2140888A (en) | Purification process | |
| DE3065316D1 (en) | Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process | |
| JPS5329978A (en) | Cultivation medium | |
| FR2627507B1 (en) | PROCESS FOR REDUCING THE VISCOSITY OF MEDIA IN THE EVENT OF EXCRETING VISCOSIFYING POLYMERS ATTACHED TO FERMENTATION PROCESSES | |
| JPS5675095A (en) | Preparation of heat-resistant acetic acid kinase | |
| ATE21033T1 (en) | PROCESS FOR THE PRODUCTION OF AN IMMUNOGEN FROM PASTEURELLA MULTOCIDA. | |
| EP0337625A3 (en) | Probes | |
| JPS5682095A (en) | Purification of fatty acid produced through fermentation process | |
| JPS5592395A (en) | Novel antibiotic substacne neopolyoxin, and its preparation | |
| WO1990010058A3 (en) | Method for production and purification of hepatitis b vaccine | |
| JPS55149297A (en) | Antibiotic herbicidin c, e, f, and g and its preparation | |
| FR2616445B1 (en) | PROCESS FOR THE PRODUCTION OF ETHANOL USING HIGH RESISTANCE MICROORGANISM STRAINS | |
| RU93028311A (en) | METHOD FOR PRODUCING BIOLOGICALLY ACTIVE SUBSTANCES FROM BIOMASS OF CULTIVATED PLANT CELLS | |
| JPS54154713A (en) | Derivative of glucosamine | |
| JPS55102389A (en) | Novel microorganism | |
| RO94493A2 (en) | PROCESS FOR PREPARING ANAEROBIC BACTERIA CULTIVATION MEDIUM | |
| JPS5675500A (en) | Dc-11-a-3 |